Evidence map›Paper›PMID 40098468›Full record

Trial reportDiabetes technology & therapeutics2025

Inhaled Technosphere Insulin Plus Insulin Degludec for Adults with Type 1 Diabetes: The INHALE-3 Extension Study.

Roy W Beck, Ryan J Bailey, Klara R Klein, Grazia Aleppo, Carol J Levy, Jamie Diner, Christopher Jacobson, Camilla M Levister, Peter Calhoun, Katrina J Ruedy and 2 more

Abstract readRandomized Controlled TrialMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Diabetes technology & therapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Roy W BeckJAEB Center for Health Research, Tampa, Florida, USA.ORCID 0000-0002-5194-8446
Ryan J BaileyJAEB Center for Health Research, Tampa, Florida, USA.ORCID 0000-0001-5763-4598
Klara R KleinUniversity of North Carolina, Chapel Hill, North Carolina, USA.
Grazia AleppoNorthwestern University, Chicago, Illinois, USA.
Carol J LevyIcahn School of Medicine at Mount Sinai, New York, New York, USA.ORCID 0000-0002-3492-2578
Jamie DinerUniversity of North Carolina, Chapel Hill, North Carolina, USA.
Christopher JacobsonLoma Linda University, Loma Linda, California, USA.
Camilla M LevisterIcahn School of Medicine at Mount Sinai, New York, New York, USA.
Peter CalhounJAEB Center for Health Research, Tampa, Florida, USA.ORCID 0000-0002-5325-7200
Katrina J RuedyJAEB Center for Health Research, Tampa, Florida, USA.
Irl B HirschUniversity of Washington, Seattle, Washington, USA.ORCID 0000-0003-1675-8417
INHALE-3 Study Group

Funding

North Carolina Translational and Clinical Sciences Institute (NC TraCS)UM1TR004406 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI NICHOLAS J SHAHEEN · 2023 to 2026
$37.5M
NCATS NIH HHS UM1 TR004406
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 1Hypoglycemic AgentsInsulin, Long-ActingAdministration, InhalationAdultBlood GlucoseDrug Therapy, CombinationFemaleGlycated HemoglobinHumansMaleMiddle AgedYoung AdultBlood GlucoseGlycated HemoglobinHypoglycemic Agentsinsulin degludecInsulin, Long-Actingadultshyperglycemiainhaled insulinpostprandial

Identifiers

PMID40098468
PMCPMC13170934

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.